This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. | MicrobiomeTrials
← Back to trials NCT06772064
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-04-15Est. Completion: 2025-12-01
Enrollment target: 115 participantsLocations Qilu Hospital of Shandong University, Jinan, Shandong, China Other microbiome trials you might be interested in Pancreatic Adenocarcinoma Weight Loss
The purpose of this study is to prospectively analyze the prevalence of SIBO in patients with Pancreatic adenocarcinoma …
Los Angeles, United States Est. completion Oct 14, 2028
Recurrent Soft Tissue Sarcoma of the Trunk and Extremities Resectable Soft Tissue Sarcoma of the Trunk and Extremities Soft Tissue Sarcoma of the Trunk and Extremities Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
This clinical trial compares the effect of short-course ultrahypofractionated radiation therapy over 5 days (UHRT-5) to …
Birmingham, United States Est. completion Apr 30, 2029
Irritable Bowel Syndrome (IBS) Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal ba…
Baltimore, United States Est. completion Dec 31, 2027